AKT1 and esophageal squamous cell carcinoma: Combining anti-VEGF and anti-ANG2 treatments showed strong, synergistic effects against these cancers.462 Another recent study reported that MFGE8 activates the ERK/AKT pathway to promote angiogenesis in esophageal squamous cell carcinoma (ESCC).